Bellevue Group’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,817
Closed -$523K 168
2025
Q4
$523K Buy
11,817
+2,124
+22% +$119K 0.01% 132
2025
Q3
$709K Sell
9,693
-14,123
-59% -$921K 0.01% 111
2025
Q2
$1.46M Hold
23,816
0.03% 100
2025
Q1
$1.38M Sell
23,816
-4,095
-15% -$259K 0.03% 103
2024
Q4
$1.49M Sell
27,911
-1,149
-4% -$56.3K 0.03% 111
2024
Q3
$1.27M Sell
29,060
-43,095
-60% -$1.44M 0.02% 114
2024
Q2
$2.02M Sell
72,155
-71,910
-50% -$1.9M 0.03% 111
2024
Q1
$3.88M Sell
144,065
-119,970
-45% -$3.42M 0.06% 102
2023
Q4
$7.4M Sell
264,035
-135,422
-34% -$3.2M 0.11% 90
2023
Q3
$8.48M Sell
399,457
-49,122
-11% -$1.34M 0.14% 94
2023
Q2
$15.3M Hold
448,579
0.22% 88
2023
Q1
$14.5M Hold
448,579
0.21% 87
2022
Q4
$15.1M Buy
448,579
+255,140
+132% +$7.79M 0.2% 92
2022
Q3
$5.85M Buy
193,439
+57,117
+42% +$2.09M 0.08% 109
2022
Q2
$4.75M Buy
136,322
+53,462
+65% +$2.1M 0.07% 113
2022
Q1
$4.32M Buy
+82,860
New +$4.17M 0.05% 121

Other funds holding DOCS

Bellevue Group's DOCS Position: Q1 2026 in Review

Bellevue Group sold out of Doximity (DOCS) in Q1 2026, closing a stake of 11,817 shares — an estimated $523K sold.

Bellevue Group first reported a position in DOCS in Q1 2022 and held it in 16 quarters. The position peaked at $15.3M in Q2 2023. 421 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Bellevue Group reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
  • Bellevue Group sold 11,817 Doximity shares in Q1 2026, an estimated $523K.
  • Bellevue Group first reported a position in Doximity in Q1 2022 and held it in 16 quarters.
  • Bellevue Group's Doximity position peaked at $15.3M in Q2 2023.
  • 421 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.